TipRanks
Go Ultimate55% OFF
PC:ELY3X

Elysium Therapeutics: Valuation, Funding & Investors

1201 E Market St. Suite 604 Akron, OH 44305, UShttps://www.elysiumrx.com/Therapeutics

Elysium Therapeutics is an emerging biopharmaceutical company developing treatments to prevent and reverse overdoses caused by highly potent synthetic opioids, with a specific focus on oral fentanyl and nitazenes. The company is advancing SOOPR™, a rapid-onset, long-acting naloxone prodrug rescue therapy, and developing SMART™ and O2P™ product approaches to improve opioid safety and reduce overdose fatalities.

Leadership & Board

Current Number of Employees
4
Current LinkedIn Followers
290

Latest Estimated Valuation

Total Amount Raised
$8M
Total Funding Rounds
1
Latest Funding Amount
$8M
Latest Funding Round
Convertible Notes

Employee Trend

Elysium Therapeutics had 4 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.

4Latest Employee Count
0(0.00%)Week-Over-Week Change
01234Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026

Social Trend

Elysium Therapeutics had 290 followers as of October 26, 2026. The number of followers increased by 1 (0.35%) week-over-week.

290Latest Followers Count
1(0.35%)Week-Over-Week Change
0100200300400Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 28, 2026Convertible Notes$7.50M―

Similar Companies

A snapshot of private companies similar to Elysium Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis